Related Experiment Videos
[Structure and function of a cell-associated complement regulatory protein, membrane cofactor protein (MCP)].
1Department of Immunology, Center for Adult Diseases, Osaka.
Summary
Researchers identified a new protein, membrane cofactor protein (MCP), on human leukocytes. This protein, distinct from CR1, helps regulate complement system activation, working with DAF to protect cells from damage.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Human leukocytes possess complement regulatory factor I cofactor activity distinct from C3b/C4b receptor (CR1).
- Understanding these regulatory proteins is crucial for comprehending immune response and self-protection mechanisms.
Purpose of the Study:
- To purify and characterize a novel cofactor protein from human leukocyte cell lines.
- To elucidate the structural and functional properties of this newly identified protein.
- To investigate its role in the complement system and its relationship with other regulatory proteins.
Main Methods:
- Purification of the cofactor protein from human leukocyte cell lines.
- Assessment of structural properties including molecular weight (SDS-PAGE), isoelectric point (pI), amino acid composition, and glycosylation.
- Functional assays to determine cofactor activity for Factor I-mediated cleavage of C3b and interaction with complement components (C3b, C4b).
Main Results:
- The purified protein, named membrane cofactor protein (MCP), has a molecular weight of 45,000-70,000 daltons.
- MCP exhibits specific binding to C3b and C4b, possesses an acidic pI (around pH 4), and is rich in proline.
- It acts as a cofactor for Factor I in C3b cleavage, generating iC3b, and shares properties with complement regulatory proteins CR1, H, and C4bp.
Conclusions:
- MCP is a novel membrane-bound cofactor protein with regulatory functions in the complement system.
- Its functional profile is complementary to decay-accelerating factor (DAF), suggesting a synergistic role in inhibiting complement activation on autologous tissues.
- The widespread distribution of DAF and MCP on peripheral blood cells likely contributes to protecting self-tissues from complement-mediated damage.